ArticleJournal of fluorescence2026
Engineering a Synthetic Fluorogenic RNA Switch for Oxidized Guanine.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Reactive oxygen species generate a family of oxidized guanine species that serve as important biomarkers of oxidative damage. Here, we report the development of a fluorogenic RNA switch that selectively recognizes oxidized guanine species. We first systematically characterized an oxidized guanine RNA aptamer, defining its minimum functional binding domain and molecular recognition profile. Structural minimization produced a compact aptamer with higher affinity than the full-length sequence that retained broad recognition of structurally diverse oxidized guanine species while discriminating against their unmodified counterparts. We subsequently incorporated the optimized aptamer into fluorogenic RNA switch architectures, revealing that fluorescence activation required iterative optimization of aptamer topology, scaffold architecture, and communication-linker design. The resulting fluorogenic RNA switch exhibited target-dependent fluorescence activation while retaining the aptamer's molecular recognition profile. This work establishes a fluorogenic RNA switch for oxidized guanine species and highlights the importance of systematic aptamer characterization and optimization in fluorogenic RNA switch development.
Indexed as
Identifiers
42891760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.